Research in schizophrenia and the discontinuation of antipsychotic medications

Schizophrenia Bulletin

Volumn 23, Issue 1, 1997, Pages 3-9

  Wyatt, Richard Jed ^a  

^a NATIONAL INSTITUTE OF MENTAL HEALTH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; CLINICAL RESEARCH; DRUG WITHDRAWAL; FOLLOW UP; HUMAN; PRIORITY JOURNAL; RISK ASSESSMENT; RISK BENEFIT ANALYSIS; SCHIZOPHRENIA;

EID: 0031036209     PISSN: 05867614     EISSN: None     Source Type: Journal    
DOI: 10.1093/schbul/23.1.3     Document Type: Article

References (45)

1. Angrist, B., and Schulz, S.C. The neuroleptic-nonresponsive patient: Characterization and treatment. In: Spiegel, D., ed. Progress in Psychiatry. Monograph No. 30. Washington, DC: American Psychiatric Press, 1990. pp. xvii-xxviii.
2. Baldessarini, R.J., and Viguera, A.C. Neuroleptic withdrawal in schizophrenic patients. Archives of General Psychiatry, 52:189-192, 1995.
3. Bleuler, M. The Schizophrenic Disorders: Long-Term Patient and Family Studies. Translated by S.M. Clemens. New Haven, CT: Yale University Press, 1978.
4. Cardon, P.V.; Dommel, F.W.; and Trumble, R.R. Injuries to research subjects: A survey of investigators. New England Journal of Medicine, 295:650-654, 1976.
5. Carpenter, W.T., Jr., and Tamminga, C.A. Why neuroleptic withdrawal in schizophrenia? Archives of General Psychiatry, 52:192-193, 1995.
6. Carroll, R.S.; Miller, A.; Ross, B.; and Simpson, G.M. Research as an impetus to improved treatment. Archives of General Psychiatry, 37:377-380, 1980.
7. Ciompi, L. The natural history of schizophrenia in the long term. British Journal of Psychiatry, 136:420-423, 1980.
8. Curson, D.A.; Barnes, T.R.E.; Bamber, R.W.; Platt, S.D.; Hirsch, S.R.; and Duffy, J.C. Long-term depot maintenance of chronic schizophrenic out-patients: The seven-year follow-up of the Medical Research Council fluphenazine/placebo trial. British Journal of Psychiatry, 146:464-480, 1985.
9. Ey, H.; Igert, C.; and Rappard, P.H. Psychoses aiguës et évolutions schizophréniques dans un service de 1930 à 1956. Annales Médipsychologiques, 115:231-240, 1957.
10. Falloon, I.R.H. Early intervention for episodes of schizophrenia: A preliminary exploration. Psychiatry, 55:4-15, 1992.
11. Fink, M., and Sackeim, H.A. Convulsive therapy in schizophrenia? Schizophrenia Bulletin, 22(1):27-39, 1996.
12. Gilbert, P.L.; Harris, M.J.; McAdams, L.A.; and Jeste, D.V. Neuroleptic withdrawal in schizophrenic patients: A review of the literature. Archives of General Psychiatry, 52:173-188, 1995.
13. Giller, E., and Strauss, J. Clinical research: A key to clinical training. American Journal of Psychiatry, 141:1075-1077, 1984.
14. Greden, J.F., and Tandon, R. Long-term treatment for lifetime disorders? Archives of General Psychiatry, 52:197-200, 1995.
15. Hare, E.H. Was insanity on the increase? British Journal of Psychiatry, 142:439-455, 1983.
16. Hirsch, S.R.; Gaind, R.; Rohde, P.D.; Stevens, B.C.; and Wing, J.K. Outpatient maintenance of chronic schizophrenic patients with long-acting fluphenazine: Double-blind placebo trial. Report to the Medical Research Council Committee on Clinical Trials in Psychiatry. British Medical Journal, 17:633-637, 1973.
17. Isaac, R.J., and Armat, V.C. Madness in the Streets: How Psychiatry and the Law Abandoned the Mentally III. New York, NY: The Free Press, 1990.
18. Jeste, D.V.; Gilbert, P.L.; McAdams, L.A.; and Harris, M.J. Considering neuroleptic maintenance and taper on a continuum: Need for individual rather than dogmatic approach. Archives of General Psychiatry, 52:209-212, 1995.
19. Johnson, D.A.W.; Pasterski, G.; Ludlow, J.M.; Street, K.; and Taylor, R.D.W. The discontinuance of maintenance neuroleptic therapy in chronic schizophrenic patients: Drug and social consequences. Acta Psychiatrica Scandinavica, 67:339-352, 1983.
20. Johnstone, B.C.; Macmillan, J.F.; Frith, C.D.; Benn, D.K.; and Crow, T.J. Further investigation of the predictors of outcome following first schizophrenic episodes. British Journal of Psychiatry, 157:182-189, 1990.
21. Kalman, T.P.; Talon, N.S.; Frances, A.; and Kocsis, J.H. A controlled study of satisfaction among psychobiology research patients. American Journal of Psychiatry, 139:344-347, 1982.
22. Kendell, R.E.; Malcolm, D.E.; and Adams, W. The problem of detecting changes in the incidence of schizophrenia. British Journal of Psychiatry, 162:212-218, 1993.
23. Kocsis, J.H.; Frances, A.; Kaiman, T.P.; and Shear, M.K. The effect of psychobiological research on treatment outcome: A controlled study. Archives of General Psychiatry, 38:511-515, 1981.
24. Loebel, A.D.; Lieberman, J.A.; Alvir, J.M.J.; Mayerhoff, D.I.; Geisler, S.H.; and Szymanski, S.R. Duration of psychosis and outcome in first-episode schizophrenia. American Journal of Psychiatry, 149:1183-1188, 1992.
25. Macklin, R. "Due" and "undue" inducements: On paying money to research subjects. IRB, 31:1-2, 1981.
26. Matthews, S.M.; Roper, M.T.; Mosher, L.R.; and Menn, A.Z. A non-neuroleptic treatment for schizophrenia: Analysis of the two-year postdischarge risk of relapse. Schizophrenia Bulletin, 5(2):322-333, 1979.
27. May, P.R.A.; Tuma, A.H.; and Dixon, W.J. Schizophrenia: A follow-up study of results of treatment: I. Design and other problems. Archives of General Psychiatry, 33:474-478, 1976a.
28. May, P.R.A.; Tuma, A.H.; and Dixon, W.J. Schizophrenia: A follow-up study of results of five forms of treatment. Archives of General Psychiatry, 38:776-784, 1981.
29. May, P.R.A.; Tuma, A.H.; Yale, C.; Potepam, P.; and Dixon, W.J. Schizophrenia: A follow-up study of results of treatment: II. Hospital stay over two to five years. Archives of General Psychiatry, 33:481-486, 1976b.
30. McCrae, R. R. Are stress questionnaires stressful? IRB, 4:1-2, 1982.
31. McEvoy, J.P.; Schooler, N.R.; and Wilson, W.H. Predictors of therapeutic response to haloperidol in acute schizophrenia. Psychopharmacology Bulletin, 27(1): 97-101, 1991.
32. Meltzer, H.Y. Neuroleptic withdrawal in schizophrenic patients: An idea whose time has come. Archives of General Psychiatry, 52:200-202, 1995.
33. Nuechterlein, K.H.; Gitlin, M.J.: and Subotnik, K.L. The early course of schizophrenia and long-term maintenance neuroleptic therapy. Archives of General Psychiatry, 52:203-205, 1995.
34. Ram, R.; Bromet, E.J.; Eaton, W.W.; Pato, C.; and Schwartz, J.E. The natural course of schizophrenia: A review of first-admission studies. Schizophrenia Bulletin, 18(2): 185-207, 1992.
35. Stephens, J.H. Long-term course and prognosis in schizophrenia. Seminars in Psychiatry, 2:464-485, 1970.
36. Szymanski, S.R.; Lieberman, J.A.; Alvir, J.M.J.; Mayerhoff, D.; Loebel, A.I.; Geisler, S.D.; Chakos, M.; Koreen, A.; Jody, D.H.; Kane, J.M.; Woerner, M.; and Cooper, T. Gender differences in onset of illness, treatment response, course, and biologic indexes in first-episode schizophrenic patients. American Journal of Psychiatry, 152:698-703, 1995.
37. Tantum, D. Discussion. British Journal of Psychiatry, 143:83-84, 1983.
38. Waddington, J.L., and Youssef, H.A. Evidence for a gender-specific decline in the rate of schizophrenia in rural Ireland over a 50-year period. British Journal of Psychiatry, 164:171-176, 1994.
39. Waddington, J.L.; Youssef, H.A.; and Kinsella, A. Sequential cross-sectional and ten-year prospective study of severe negative symptoms in relation to duration of initially untreated psychosis in chronic schizophrenia. Psychological Medicine, 25:849-857, 1995.
40. Watt, D.C.; Katz, K.; and Shepherd, M. The natural history of schizophrenia: A 5-year prospective follow-up of a representative sample of schizophrenics by means of standardized clinical and social assessment. Psychological Medicine, 13:663-670, 1983.
41. Wyatt, R.J. Neuroleptics and the natural course of schizophrenia. Schizophrenia Bulletin, 17(2):325-351, 1991.
42. Wyatt, R.J. Antipsychotic medication and the long-term course of schizophrenia: Therapeutic and theoretical implications. In: Shriqui, C., and Nasrallah, H., eds. Contemporary Issues in the Treatment of Schizophrenia. Washington, DC: American Psychiatric Press, 1995a. pp. 385-410.
43. Wyatt, R.J. Early intervention for schizophrenia: Can the course of the illness be altered? Biological Psychiatry, 38:1-3, 1995b.
44. Wyatt, R.J. Risks of withdrawing antipsychotic medications. Archives of General Psychiatry, 52:205-208, 1995c.
45. Wyatt, R.J.; Piña, L.M.; and Henter, I. First-episode schizophrenia: Early intervention and medication discontinuation in the context of course and treatment. British Journal of Psychiatry, in press.